Technical Analysis for AMYT - Amryt Pharma plc

Grade Last Price % Change Price Change
grade B 12.6 -1.18% -0.15
AMYT closed down 1.18 percent on Tuesday, October 20, 2020, on 15 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Flat
Historical AMYT trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Gapped Down Weakness 0.00%
Narrow Range Bar Range Contraction -1.18%
NR7 Range Contraction -1.18%
Gapped Up Strength -1.18%
20 DMA Support Bullish 1.12%
Three Weeks Tight Range Contraction 1.12%
Inside Day Range Contraction 1.12%
Older End-of-Day Gignals for AMYT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 1% about 14 hours ago
Fell Below 10 DMA about 14 hours ago
Fell Below Previous Day's Low about 14 hours ago
Rose Above Previous Day's High 1 day ago
Rose Above 10 DMA 1 day ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Amryt Pharma Plc is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. It operates through the following segments: Commercial, Research and Development. The Commercial segment includes the financial results of the Group's two current commercial product lines, Imlan and Lojuxta. The Research and Development segment comprises the financial results of the Group's two current research and development assets, AP101 and AP102. The company was founded by Joseph Amrit Wiley and Rory Peter Nealon on August 28, 2015 and is headquartered in Dublin, Ireland.
Health Pharmaceutical Pharmaceutical Industry Pharmacy Pharmacology Rare And Orphan Diseases

Is AMYT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.5
52 Week Low 0.0
Average Volume 29,192
200-Day Moving Average 0.00
50-Day Moving Average 12.00
20-Day Moving Average 12.45
10-Day Moving Average 12.61
Average True Range 0.66
ADX 14.87
+DI 27.96
-DI 23.24
Chandelier Exit (Long, 3 ATRs ) 11.57
Chandelier Exit (Short, 3 ATRs ) 12.81
Upper Bollinger Band 13.38
Lower Bollinger Band 11.53
Percent B (%b) 0.58
BandWidth 14.80
MACD Line 0.17
MACD Signal Line 0.21
MACD Histogram -0.044
Fundamentals Value
Market Cap 410.26 Million
Num Shares 32.6 Million
EPS
Price-to-Sales 2.41
Price-to-Book 5.09
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.90
Resistance 3 (R3) 12.90 12.80 12.85
Resistance 2 (R2) 12.80 12.72 12.80 12.83
Resistance 1 (R1) 12.70 12.68 12.65 12.70 12.82
Pivot Point 12.60 12.60 12.58 12.60 12.60
Support 1 (S1) 12.50 12.52 12.45 12.50 12.38
Support 2 (S2) 12.40 12.48 12.40 12.37
Support 3 (S3) 12.30 12.40 12.35
Support 4 (S4) 12.30